U.S. Venture Partners (USVP)

Profile

USVP
U.S. Venture Partners (USVP) is a leading Silicon Valley venture capital firm, partnering with entrepreneurs to transform their ideas into world-changing companies. USVP has invested in over 500 companies spanning four decades, including: Box, Check Point Software, Guidewire, HeartFlow, HotelTonight, Imperva, Inari Medical, Inspire Medical Systems, Intersect ENT, Luminate, Omada Health, ON24, Pluto TV, Prevoty, Sequent, Silverback Therapeutics, ThreatMetrix, Trunk Club, Trusteer, Vontu, Yammer and Zerto. USVP focuses on early-stage start-ups that transform cybersecurity, enterprise software, consumer and healthcare. The USVP team consists of former entrepreneurs, technologists, corporate executives, and financial professionals who assist with strategy, scaling, team building, product development, and business development. USVP is based in Menlo Park, California.

The USVP team foundation is grounded in four generations of high-technology venture investing. We are accomplished venture investors, former CEOs, senior executives and technology company founders that came together to take an exemplary firm into the 21st century. Together, we combine 150 years of operating experience and investment expertise with varied backgrounds in marketing, sales, operations, finance, engineering, computing, research and management.



We work very closely with our executives over several years, usually serving on a company’s Board of Directors. You have access, not just to your USVP board member, but also to all of the USVP team. You have the ability to draw upon the firm’s deep industry expertise, technical strengths, team approach, network of outstanding individuals, and access to capital from “blue chip” limited partners, all who have made a positive impact on hundreds of companies.



Our personnel make up and the firm heritage combine to make us part of the company building process and in most situation our partner on the board is the first call the entrepreneur makes when faced with strategic decisions, daily challenges and personal support, knowing that we will be there to provide the counsel needed, which is grounded in decades of experience but with the humble understanding of our role as coaches and confidantes.

SAAS+CLOUD
The transition of the trillion-dollar enterprise software and IT infrastructure to SaaS and Cloud is the largest transformation the industry has seen. Despite the huge successes, we are still in the early stage of this revolution. USVP has strong leadership in this area through its historic network and recent investments in Box, Guidewire, Hellosign, Human Interest, Rimeto, Smartling, Yammer, Zerto and others. We pull on this tremendous experience to find the best investments and grow companies in the next industry leaders.

SECURITY
USVP has been a pioneer in the security space with early investments such as Checkpoint, Cyphertrust and Vontu. Market leadership in security investing comes from identifying emerging trends on the threat horizon, partnering with the best team to build the best product, and executing on an efficient “go-to market” strategy. Best of breed solutions in a specific sector have a long history of success and are exemplified by our more recent winners Cato Networks, Imperva, Kenna Security, Luminate, Prevoty, Threatmetrix, and Trusteer.

CONSUMER
The ubiquitous presence of the Internet and mobile has given consumers unparalleled information and services accessible from anywhere. The connected consumer leverages technology in all aspects of their life, combining experiences in the physical and digital worlds by amplifying existing actions and completely new services or interactions. USVP has developed a unique approach to understand and develop valuable consumer powerhouses such as GoPro, Trunkclub, HotelTonight, PlutoTV and Primary and is looking for the next big consumer opportunities.

HEALTHCARE
USVP healthcare team has a unique competence in investing in medical devices, biotechnology and healthcare information technology sectors, with a focus on therapeutic medical devices that enable new or less invasive procedures, molecularly targeted protein or small molecule therapeutics, and information technology-enabled healthcare services, which improve the quality of care and/or significantly reduce costs. Big successes such as Atheromed, Castlight, Inari, Inspire, IntersectENT, Nanostim, Proteolix, Sequent Medical and emerging companies like Omada, HeartFlow, Silverback, Ribon and Route 92 demonstrate our track record.